Viewing Study NCT06973161


Ignite Creation Date: 2025-12-24 @ 1:02 PM
Ignite Modification Date: 2026-01-28 @ 3:06 PM
Study NCT ID: NCT06973161
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2025-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
None Biliary Tract Cancer View
None Cervical Cancer View
None Endometrial Cancer View
None Ovarian Cancer View
None Pancreatic Cancer View
None Colorectal Cancer View
None Lung Cancer View
None Other Tumors View
Keywords: